-
Pfizer's Xalkori makes it onto Cancer Drugs Fund
pharmatimes
July 11, 2018
NICE has published draft guidance recommending that Pfizer's Xalkori (crizotinib) to treat ROS1-positive advanced non-small-cell lung cancer is made available via the Cancer Drugs Fund (CDF).
-
Pivotal bioVenture Partners debuts $150M China-focused biotech fund
fiercebiotech
May 28, 2018
The Nan Fung Group’s venture capital firm Pivotal bioVenture Partners has raised a $150 million venture fund to help early-stage life science companies located within China.
-
Theresa May unveils £75m prostate cancer research fund
pharmatimes
April 11, 2018
Prime Minister Theresa May has announced an investment of £75 million into research targeting earlier diagnosis and better treatment for men with prostate cancer.
-
IDEAYA Biosciences Nabs $94 Million
biospace
March 16, 2018
IDEAYA Biosciences completed another successful fundraising campaign with the support of GV (formerly Google Ventures) and Roche Venture Capital Fund
-
Biotechs Drool as VC Firm Andreessen Horowitz Doubles Down on the Life Sciences With New $450M Fund
biospace
December 18, 2017
Biotechs are taking notice as a new pool of funding is being made available by venture capital Andreesen Horowitz. This is the second fund from the VC that is aimed at life sciences. In 2015, the firm established a fund with $200 million for investments.
-
Roche’s Erivedge no longer be financed on the NHS as skin cancer treament
pharmatimes.
November 24, 2017
Roche’s Erivedge will indeed no longer be funded on the National Health Service as a treatment for skin cancer after cost regulators issued final guidance ruling that it is not cost effective.
-
Frazier Healthcare Partners raises $419M for life science venture fund, signaling huge interest in h
biospectrumasia
November 07, 2017
The health-focused venture capital firm has announced that it has raised $419 million for its most recent life sciences investment fund, surpassing a goal of $400 million.
-
Netmeds raises $14 m from Tanncam, Sistema Asia Fund
expressbpd
November 01, 2017
The investment will be used to continue to build upon Netmeds’ consumer base and expand its reach to more locations in the country
-
23andMe raises $250m in financing, research points towards its future
pharmafile
September 14, 2017
23andMe made two announcements on the same day that point towards the future of its business: it revealed it had raised $250 million in financing and released details from a long-running study into Parkinson’s disease.
-
Abbott and the Abbott Fund donate $1 million to support Hurricane Harvey relief efforts
worldpharmanews
September 01, 2017
Abbott (NYSE: ABT) and its foundation, the Abbott Fund, are providing $1 million in grants and healthcare and nutrition products to help deliver immediate relief following Hurricane Harvey and the devastating flooding affecting Texas and Louisiana.